Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting21-05-2024
21-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015)17-05-2024
Eris Lifesciences Ltd - 540596 - Update on board meeting
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 ,inter alia, to consider and approve Update on board meeting - Fund Raising17-05-2024
Eris Lifesciences Ltd - 540596 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund15-05-2024
Eris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024.
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 ,inter alia, to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended March 31, 2024.14-05-2024
Eris Lifesciences Ltd - 540596 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund07-05-2024
Eris Lifesciences Ltd - 540596 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund & PACs06-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING02-05-2024
Eris Lifesciences Ltd - 540596 - CERTIFICATE UNDER REGULATION 40(9) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS), 2015 FOR THE YEAR ENDED MARCH 31, 2024
Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015.24-04-2024
Eris Lifesciences Ltd - 540596 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulation, 2015, For The Period Ended March 31, 2024.
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulation, 2015, for the period ended March 31, 2024.16-04-2024